3 completed, 1 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Recruiting 1 |
Follow Urticaria, Solar: new trials by email Literature Review of Urticaria, Solar trials Research Report on Urticaria, Solar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria Remibrutinib, Placebo - Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU) | Phase 2 | Recruiting | Novartis Pharmaceuticals | 44 | 2025-05-22 | 2026-09-28 |
| Omalizumab in Severe and Refractory Solar Urticaria Omalizumab - Solar Urticaria | Phase 2 | Completed | Centre Hospitalier Universitaire de Besancon | 10 | 2014-09-30 | 2018-10-12 |
| Intravenous Immunoglobulins in Severe and Refractory Solar Urticaria Intravenous immunoglobulins - Solar Urticaria | Phase 2 | Completed | Centre Hospitalier Universitaire de Besancon | 10 | 2011-06-01 | 2013-07-30 |
| Phase II Solar Urticaria (SU) Pilot Study afamelanotide - Solar Urticaria | Phase 2 | Completed | Clinuvel Pharmaceuticals Limited | 5 | 2008-12-01 | 2009-09-15 |
Chronic Inducible Urticaria (1) · Chronic Urticaria (1) · Cold Urticaria (1) · Familial dermographism (1)
Chronic Disease (4) · Disease Attributes (4) · Hypersensitivity (4) · Hypersensitivity, Immediate (4) · Immune System Diseases (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Photosensitivity Disorders (4) · Skin Diseases (4) · Skin Diseases, Vascular (4) · Skin and Connective Tissue Diseases (4) · Urticaria (4) · Chronic Inducible Urticaria (3) · Chronic Urticaria (3)
Immunoglobulins, Intravenous (1) · Omalizumab (1) · afamelanotide (1) · remibrutinib (1)
Centre Hospitalier Universitaire de Besancon (2) · Clinuvel Pharmaceuticals Limited (1) · Novartis Pharmaceuticals (1)
France (3) · Germany (1) · Poland (1) · Spain (1) · United Kingdom (1) · United States (1)
Lesley Rhodes, M.D. (1) · Manuelle Viguier, Dr (1) · Manuelle Viguier, MD, PhD (1)